This is an old revision of the document!
Tibotec
Tibotec was a biopharmaceutical company based in Belgium. It was acquired by Johnson & Johnson in April 2002.1)
Activities
Tibotec provided funding for HIV treatment clinical trials at the Infectious Diseases Institute in Kampala, Uganda, including trials involving David Boulware.2) 3)
External links
1)
Johnson & Johnson to Acquire Tibotec-Virco. (2002, March 22). Johnson & Johnson. https://web.archive.org/web/20020608123005/http://www.investor.jnj.com/ReleaseDetail.cfm?ReleaseID=75177
2)
Clinical Research at the Infectious Diseases Institute. The Global Health Network; Infectious Diseases Institute. Retrieved May 17, 2023, from https://web.archive.org/web/20230517060735/https://media.tghn.org/site_finder/sites/documents/Clinical_Research_at_IDI.pdf
3)
Schmickle, S. (2008, November 13). University of Minnesota doctors battle AIDS in Uganda. MinnPost. http://archive.today/2010.06.23-113510/http://www.minnpost.com/stories/2008/11/13/4537/university_of_minnesota_doctors_battle_aids_in_uganda